Pregled bibliografske jedinice broj: 1240224
The burden and epidemiology of anaerobic bacteraemia: a retrospective multi-centre multi- national cross-sectional study
The burden and epidemiology of anaerobic bacteraemia: a retrospective multi-centre multi- national cross-sectional study // 31st European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2019)
Beč, Austrija, 2021. str. /-/ (predavanje, međunarodna recenzija, sažetak, znanstveni)
CROSBI ID: 1240224 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
The burden and epidemiology of anaerobic
bacteraemia: a retrospective multi-centre multi-
national cross-sectional study
Autori
Join-Lambert, O ; Guet-Revillet, H ; Dumont, Y ; Justesen, U ; Boyer, P ; Morris, T ; Pranada, A ; Rompf, C ; Pierard, D ; Wybo, I ; Novak, Anita ; Riverain Gillet, E ; Cobo Martínez, F ; Jean- Pierre, H ; Malandain, D ; Antonini, L ; Sóki, J ; Gajdacs, M ; Baaity, Z ; Jamal, W ; Veloo, L ; Cordovana, M, Ambretti, S ; Assous, M ; Safarika, A ; Giannistisioti, E ; Nurver, U ; Verdon, R ; Le Hello, S ; Parienti, JJ
Kolaboracija
ESGAI
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Skup
31st European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2019)
Mjesto i datum
Beč, Austrija, 09.07.2021. - 12.07.2021
Vrsta sudjelovanja
Predavanje
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
anaerobes, ESGAI, resistance, anaerobic bacteraemia
Sažetak
The burden of anaerobic bacteremia ranged from 2 to 14% of patients with positive BCs among centers, reflecting different hospital sizes and medical activities. Cutibacterium acnes was the most frequently recovered anaerobe in some centers, suggesting different medical activities / BCs laboratory procedures. Antimicrobial resistance rate in the B. fragilis group is worrisome. It may be associated with treatment failures and requires continuous surveillance.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti